Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06174428 · ClinicalTrials.gov registry record
Validity of Viome's Oral/throat Cancer Test
A clinical trial of Oropharyngeal Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma, sponsored by Viome.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT06174428 is a study of Oropharyngeal Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma that is actively recruiting participants, run by Viome. The registered enrollment target is 1,000 participants, above the 145-participant average among 14 other Oropharyngeal Squamous Cell Carcinoma trials with a reported enrollment target (590% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06174428, a study of Oropharyngeal Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma, is actively recruiting participants, sponsored by Viome.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
A total of at least 1,000 participants with suspicion of cancer including at least 107 subjects who will be diagnosed with OSCC or OPSCC will be enrolled from either primary or secondary care centers in the U.S. Clinicians will use Viome collection kits to collect saliva samples from eligible patients.
Conditions Studied
Interventions
- DEVICE Oral/Throat cancer test
Study Locations (2)
Missouri
- Missouri School of Dentistry & Oral Health - St Louis
Tennessee
- UTHSC - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06174428
The ClinicalTrials.gov registry entry for NCT06174428 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 145-participant average among 14 other Oropharyngeal Squamous Cell Carcinoma trials with a reported enrollment target (590% higher). The listed sponsor is Viome, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Oropharyngeal Squamous Cell Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Oral/Throat cancer test is the first listed.
NCT06174428 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Missouri, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06174428 about?
NCT06174428 is a clinical study titled "Validity of Viome's Oral/throat Cancer Test". A total of at least 1,000 participants with suspicion of cancer including at least 107 subjects who will be diagnosed with OSCC or OPSCC will be enrolled from either primary or secondary care centers in the U.S. Clinicians will use Viome collection kits to collect saliva samples from eligible patien...
What is the current status of trial NCT06174428?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-01-27. Estimated completion is 2026-12.
What conditions does trial NCT06174428 study?
This clinical trial studies the following conditions: Oropharyngeal Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma, Oral and Throat Cancer.
What interventions are being tested in trial NCT06174428?
The interventions under investigation include: Oral/Throat cancer test (DEVICE).
Who is sponsoring clinical trial NCT06174428?
This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06174428 being conducted?
This trial has 2 study locations across Missouri, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oropharyngeal Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
RECRUITING · Phase 2
-
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
RECRUITING · Phase 2
-
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
RECRUITING
-
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
RECRUITING · Early Phase 1
-
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.
RECRUITING · Phase 2
-
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Oropharyngeal Squamous Cell Carcinoma
All registered trials for this condition
Oral Squamous Cell Carcinoma
All registered trials for this condition
Missouri
All trials with a study site in Missouri
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.